CAS: 494753-69-4

Ginsenoside Rk1 - Ginsenoside Rz1 (5:2) is a complex phytochemical formulation, which is derived from Panax ginseng, a medicinal herb renowned for its bioactive compounds. Ginsenosides, the primary active components, are triterpene saponins known for their diverse pharmacological properties. In this specific formulation, Ginsenoside Rk1 and Ginsenoside Rz1 are combined in a 5:2 ratio, creating a synergistic profile that enhances their biological efficacy. The mode of action involves modulation of various cellular pathways. Notably, these ginsenosides interact with cellular receptors and enzymatic pathways that regulate apoptosis, proliferation, and inflammatory responses. Through these interactions, Ginsenoside Rk1 - Ginsenoside Rz1 influences signaling pathways such as MAPK and NF-kB, which play critical roles in cancer cell survival and inflammatory processes. This ginsenoside formulation is primarily investigated for its potential anticancer and anti-inflammatory applications. Research indicates promising effects in inhibiting tumor growth and reducing inflammation, thus highlighting its potential as a therapeutic agent in oncology and immune-related conditions. Scientists are keenly exploring these ginsenosides for their role in elucidating new therapeutic strategies.

Ginsenoside Rk1 is a component created by processing the ginseng plant at high temperatures.

Please enquire for more information about Ginsenoside Rk including the price, delivery time and more detailed product information at the technical inquiry form on this page

Ginsenoside Rk1, one of the main elements of Sung Ginseng, has been confirmed as a new endothelial barrier enhancer recently and has anti-cancer activity, the mechanism involves coordination between inhibition of telomerase activity and induction of apoptosis.

Natural glycoside